COVID-19, ACE2, and the cardiovascular consequences
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
The novel SARS coronavirus SARS-CoV-2 pandemic may be particularly deleterious to patients with underlying cardiovascular disease (CVD). The mechanism for SARS-CoV-2 infection is the requisite binding of the virus to the membrane-bound form of angiotensin-converting enzyme 2 (ACE2) and internalization of the complex by the host cell. Recognition that ACE2 is the coreceptor for the coronavirus has prompted new therapeutic approaches to block the enzyme or reduce its expression to prevent the cellular entry and SARS-CoV-2 infection in tissues that express ACE2 including lung, heart, kidney, brain, and gut. ACE2, however, is a key enzymatic component of the renin-angiotensin-aldosterone system (RAAS); ACE2 degrades ANG II, a peptide with multiple actions that promote CVD, and generates Ang-(1–7), which antagonizes the effects of ANG II. Moreover, experimental evidence suggests that RAAS blockade by ACE inhibitors, ANG II type 1 receptor antagonists, and mineralocorticoid antagonists, as well as statins, enhance ACE2 which, in part, contributes to the benefit of these regimens. In lieu of the fact that many older patients with hypertension or other CVDs are routinely treated with RAAS blockers and statins, new clinical concerns have developed regarding whether these patients are at greater risk for SARS-CoV-2 infection, whether RAAS and statin therapy should be discontinued, and the potential consequences of RAAS blockade to COVID-19-related pathologies such as acute and chronic respiratory disease. The current perspective critically examines the evidence for ACE2 regulation by RAAS blockade and statins, the cardiovascular benefits of ACE2, and whether ACE2 blockade is a viable approach to attenuate COVID-19. Listen to this article’s corresponding podcast at: https://ajpheart.podbean.com/e/covid-19-ace2-and-the-cardiovascular-consequences/ .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897 · cited 3×
“In addition, loss of ACE2 in brain cardiovascular centers short of neuronal death may impair proper autonomic nervous system regulation of blood pressure and potentially respiration (52).”
BackgroundResultYang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., Ji, R., Wang, H., Wang, Y., & Zhou, Y. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.017 · Cited by 4,206
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445
Self-citationCOVID-19 and the cardiovascular system
Zheng, Y.-Y., Ma, Y.-T., Zhang, J.-Y., & Xie, X. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0360-5 · Cited by 2,970
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
Xu, H., Zhong, L., Deng, J., Peng, J., Dan, H., Zeng, X., Li, T., & Chen, Q. (2020) · International Journal of Oral Science · doi:10.1038/s41368-020-0074-x · Cited by 2,838
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., Yang, P., Sarao, R., Wada, T., Leong-Poi, H., et al. (2005) · Nature · doi:10.1038/nature03712 · Cited by 2,453
Zou, X., Chen, K., Zou, J., Han, P., Hao, J., & Han, Z. (2020) · Frontiers of Medicine · doi:10.1007/s11684-020-0754-0 · Cited by 2,287 · cited 2×
“23) as a coreceptor to gain intracellular entry into the lungs and brain (17, 30, 52, 53, 62).”
BackgroundLi, Y., Bai, W., & Hashikawa, T. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25728 · Cited by 2,266
Liu, Y., Yang, Y., Zhang, C., Huang, F., Wang, F., Yuan, J., Wang, Z., Li, J., Li, J., Feng, C., et al. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1643-8 · Cited by 2,031
Ferrario, C. M., Jessup, J., Chappell, M. C., Averill, D. B., Brosnihan, K. B., Tallant, E. A., Diz, D. I., & Gallagher, P. E. (2005) · Circulation · doi:10.1161/circulationaha.104.510461 · Cited by 1,565
Self-citationAngiotensin II for the Treatment of Vasodilatory Shock
Khanna, A., English, S. W., Wang, X. S., Ham, K., Tumlin, J., Szerlip, H., Busse, L. W., Altaweel, L., Albertson, T. E., Mackey, C., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1704154 · Cited by 916
Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure
Patel, V. B., Zhong, J.-C., Grant, M. B., & Oudit, G. Y. (2016) · Circulation Research · doi:10.1161/circresaha.116.307708 · Cited by 833
Iwata-Yoshikawa, N., Okamura, T., Shimizu, Y., Hasegawa, H., Takeda, M., & Nagata, N. (2019) · Journal of Virology · doi:10.1128/jvi.01815-18 · Cited by 618
Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets
Jiang, F., Yang, J., Zhang, Y., Dong, M., Wang, S., Zhang, Q., Liu, F. F., Zhang, K., & Zhang, C. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.59 · Cited by 426
Chen, D., Li, X., Song, Q., Hu, C., Su, F., Dai, J., Ye, Y., Huang, J., & Zhang, X. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.11122 · Cited by 398
The renin-angiotensin system: going beyond the classical paradigms
Santos, R. A. S., Oudit, G. Y., Verano-Braga, T., Canta, G., Steckelings, U. M., & Bader, M. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00723.2018 · Cited by 340
Sodhi, C. P., Wohlford-Lenane, C., Yamaguchi, Y., Prindle, T., Fulton, W. B., Wang, S., McCray, P. B., Chappell, M., Hackam, D. J., & Jia, H. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00498.2016 · Cited by 333
Self-citationEctodomain shedding of angiotensin converting enzyme 2 in human airway epithelia
Jia, H. P., Look, D. C., Tan, P., Shi, L., Hickey, M., Gakhar, L., Chappell, M. C., Wohlford-Lenane, C., & McCray, P. B. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00071.2009 · Cited by 329
Self-citationHuman intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors
Vuille-dit-Bille, R. N., Camargo, S. M., Emmenegger, L., Sasse, T., Kummer, E., Jando, J., Hamie, Q. M., Meier, C. F., Hunziker, S., Forras-Kaufmann, Z., et al. (2015) · Amino Acids · doi:10.1007/s00726-014-1889-6 · Cited by 312
Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis
Lovren, F., Pan, Y., Quan, A., Teoh, H., Wang, G., Shukla, P. C., Levitt, K. S., Oudit, G. Y., Al-Omran, M., Stewart, D. J., et al. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00331.2008 · Cited by 307
Wösten‐van Asperen, R. M., Lutter, R., Specht, P. A., Moll, G. N., van Woensel, J. B., van der Loos, C. M., van Goor, H., Kamilic, J., Florquin, S., & Bos, A. P. (2011) · The Journal of Pathology · doi:10.1002/path.2987 · Cited by 304
ACE2/ANG-(1–7)/Mas pathway in the brain: the axis of good
Xu, P., Sriramula, S., & Lazartigues, E. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00222.2010 · Cited by 283
Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?
Chappell, M. C. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00618.2015 · Cited by 280
Self-citationFerrario, C. M., Jessup, J., Gallagher, P. E., Averill, D. B., Brosnihan, K. B., Ann Tallant, E., Smith, R. D., & Chappell, M. C. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00675.x · Cited by 259
Self-citationACE inhibition, ACE2 and angiotensin-(17) axis in kidney and cardiac inflammation and fibrosis
Simões e Silva, A. C., & Teixeira, M. M. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.03.018 · Cited by 247
Essential role for collectrin in renal amino acid transport
Danilczyk, U., Sarao, R., Remy, C., Benabbas, C., Stange, G., Richter, A., Arya, S., Pospisilik, J. A., Singer, D., Camargo, S. M. R., et al. (2006) · Nature · doi:10.1038/nature05475 · Cited by 242
Renal ACE2 expression in human kidney disease
Lely, A., Hamming, I., van Goor, H., & Navis, G. (2004) · The Journal of Pathology · doi:10.1002/path.1670 · Cited by 239
Chappell, M. C. (2007) · Hypertension · doi:10.1161/hypertensionaha.106.076216 · Cited by 206
Self-citationChappell, M. C., Marshall, A. C., Alzayadneh, E. M., Shaltout, H. A., & Diz, D. I. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00201 · Cited by 197
Self-citationKeidar, S., Gamliel-Lazarovich, A., Kaplan, M., Pavlotzky, E., Hamoud, S., Hayek, T., Karry, R., & Abassi, Z. (2005) · Circulation Research · doi:10.1161/01.res.0000187500.24964.7a · Cited by 193
Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents
Gembardt, F., Sterner-Kock, A., Imboden, H., Spalteholz, M., Reibitz, F., Schultheiss, H.-P., Siems, W.-E., & Walther, T. (2005) · Peptides · doi:10.1016/j.peptides.2005.01.009 · Cited by 190
Wang, W., McKinnie, S. M. K., Farhan, M., Paul, M., McDonald, T., McLean, B., Llorens-Cortes, C., Hazra, S., Murray, A. G., Vederas, J. C., et al. (2016) · Hypertension · doi:10.1161/hypertensionaha.115.06892 · Cited by 190
Tikoo, K., Patel, G., Kumar, S., Karpe, P. A., Sanghavi, M., Malek, V., & Srinivasan, K. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.11.013 · Cited by 176
Huang, F., Guo, J., Zou, Z., Liu, J., Cao, B., Zhang, S., Li, H., Wang, W., Sheng, M., Liu, S., et al. (2014) · Nature Communications · doi:10.1038/ncomms4595 · Cited by 150
Wang, X., Ye, Y., Gong, H., Wu, J., Yuan, J., Wang, S., Yin, P., Ding, Z., Kang, L., Qiu, J., et al. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.05.012 · Cited by 147
ACE2 in Brain Physiology and Pathophysiology: Evidence from Transgenic Animal Models
Alenina, N., & Bader, M. (2019) · Neurochemical Research · doi:10.1007/s11064-018-2679-4 · Cited by 137
Overexpression of ACE2 Enhances Plaque Stability in a Rabbit Model of Atherosclerosis
Dong, B., Zhang, C., Feng, J. B., Zhao, Y. X., Li, S. Y., Yang, Y. P., Dong, Q. L., Deng, B. P., Zhu, L., Yu, Q. T., et al. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.164715 · Cited by 131
Jessup, J. A., Gallagher, P. E., Averill, D. B., Brosnihan, K. B., Tallant, E. A., Chappell, M. C., & Ferrario, C. M. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00061.2006 · Cited by 128
Self-citationZhong, J., Ye, J.-Y., Jin, H., Yu, X., Yu, H., Zhu, D., Gao, P., Huang, D., Shuster, M., Loibner, H., et al. (2010) · Regulatory Peptides · doi:10.1016/j.regpep.2010.09.005 · Cited by 116
Renin as a Marker of Tissue-Perfusion and Prognosis in Critically Ill Patients*
Gleeson, P. J., Crippa, I. A., Mongkolpun, W., Cavicchi, F. Z., Meerhaeghe, T. V., Brimioulle, S., Taccone, F. S., Vincent, J., & Créteur, J. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003544 · Cited by 111
Zambelli, V., Bellani, G., Borsa, R., Pozzi, F., Grassi, A., Scanziani, M., Castiglioni, V., Masson, S., Decio, A., Laffey, J. G., et al. (2015) · Intensive Care Medicine Experimental · doi:10.1186/s40635-015-0044-3 · Cited by 98
Exercise training normalizes ACE and ACE2 in the brain of rabbits with pacing-induced heart failure
Kar, S., Gao, L., & Zucker, I. H. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00840.2009 · Cited by 95
Burchill, L. J., Velkoska, E., Dean, R. G., Lew, R. A., Smith, A. I., Levidiotis, V., & Burrell, L. M. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2007.040386 · Cited by 85
Karram, T., Abbasi, A. H., Keidar, S., Golomb, E., Hochberg, I., Winaver, J. M., Hoffman, A., & Abassi, Z. A. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01186.2004 · Cited by 84
Physical Exercise and ACE2-Angiotensin-(1-7)-Mas Receptor Axis of the Renin Angiotensin System
Nunes-Silva, A., Rocha, G. C., Magalhães, D. M., Vaz, L. N., de Faria, M. H. S., & Silva, A. C. S. E. (2017) · Protein and Peptide Letters · doi:10.2174/0929866524666170728151401 · Cited by 81
Diz, D. I., Garcia-Espinosa, M. A., Gegick, S., Tommasi, E. N., Ferrario, C. M., Tallant, E. A., Chappell, M. C., & Gallagher, P. E. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2007.040261 · Cited by 75
Self-citationYuan, Y., Luo, L., Guo, Z., Yang, M. J., Ye, R.-S., & Luo, C. (2015) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320315576256 · Cited by 74
Sahara, M., Ikutomi, M., Morita, T., Minami, Y., Nakajima, T., Hirata, Y., Nagai, R., & Sata, M. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvt245 · Cited by 74 · cited 1×
“Reduced expression of ACE2 in the vasculature may also promote endothelial dysfunction and inflammation and exacerbate existing atherosclerosis and diabetes (9, 34, 42, 45, 56, 59).”
BackgroundShin, Y.-H., Min, J. J., Lee, J., Kim, G. E., Kim, G. E., Kim, M. H., Lee, J. J., & Ahn, H. J. (2016) · Heart and Vessels · doi:10.1007/s00380-016-0936-5 · Cited by 72
Yousif, M. H. M., Dhaunsi, G. S., Makki, B., Qabazard, B. A., Akhtar, S., & Benter, I. F. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.05.001 · Cited by 71
Garabelli, P. J., Modrall, J. G., Penninger, J. M., Ferrario, C. M., & Chappell, M. C. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2007.040246 · Cited by 66
Self-citationUrinary angiotensin‐converting enzyme 2 in patients with CKD
Mizuiri, S., AOKI, T., Hemmi, H., Arita, M., Sakai, K., & Aikawa, A. (2011) · Nephrology · doi:10.1111/j.1440-1797.2011.01467.x · Cited by 57
Angiotensin-converting enzyme 2 and renal disease
Williams, V. R., & Scholey, J. W. (2017) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000378 · Cited by 53
Wang, G., Lai, F. M., Lai, K., Chow, K., Kwan, B. C., Li, K.-T. P., & Szeto, C. (2008) · American Journal of Nephrology · doi:10.1159/000185629 · Cited by 44
Kim, J., Choi, S. M., Lee, J., Park, Y. S., Lee, C., Yim, J., Yoo, C., Kim, Y. W., Han, S. K., & Lee, S. (2017) · The Korean Journal of Critical Care Medicine · doi:10.4266/kjccm.2016.00976 · Cited by 43
Gilliam‐Davis, S., Gallagher, P. E., Payne, V. S., Kasper, S. O., Tommasi, E. N., Westwood, B. M., Robbins, M. E. C., Chappell, M. C., & Diz, D. I. (2011) · Physiological Genomics · doi:10.1152/physiolgenomics.00167.2010 · Cited by 23
Self-citation
Cited by
Naqvi, A. A. T., Fatima, K., Mohammad, T., Fatima, U., Singh, I. K., Singh, A., Atif, S. M., Hariprasad, G., Hasan, G. M., & Hassan, M. I. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165878 · Cited by 1,114
Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection
Lala, A., Johnson, K. W., Januzzi, J. L., Russak, A. J., Paranjpe, I., Richter, F., Zhao, S., Somani, S., Van Vleck, T., Vaid, A., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.06.007 · Cited by 791
“The mode of infection of COVID-19 is thought to be direct entry of the SARS-CoV-2 virus into cells via the human angiotensin-converting enzyme 2 (ACE2) receptor, which is expressed predominantly in the lungs but also throughout the cardiovascular system (1).”
Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study
Xiong, Q., Xu, M., Li, J., Liu, Y., Zhang, J., Xu, Y., & Dong, W. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.09.023 · Cited by 751
Bäuerle, A., Teufel, M., Musche, V., Weismüller, B., Kohler, H., Hetkamp, M., Dörrie, N., Schweda, A., & Skoda, E.-M. (2020) · Journal of Public Health · doi:10.1093/pubmed/fdaa106 · Cited by 597
Sardu, C., Gambardella, J., Morelli, M. B., Wang, X., Marfella, R., & Santulli, G. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051417 · Cited by 592
Metadata
- Authors
- South, A. M., Diz, D. I., & Chappell, M. C.
- Venue
- American Journal of Physiology-Heart and Circulatory Physiology
- Publisher
- American Physiological Society
- Published
- 2020-05-01
- Volume
- 318
- Issue
- 5
- Pages
- H1084-H1090
- ISSN
- 0363-6135 (ISSN-L)
- 1522-1539
- OpenAlex
- W3013442544
- Cited by
- 762
- References
- 58
- FWCI
- 94.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.